Description
Aptivus, containing the active ingredient tipranavir, is an antiretroviral medication used in combination with other HIV medications for the treatment of HIV-1 infection. As a non-peptidic protease inhibitor, Aptivus plays a crucial role in inhibiting the replication of the HIV virus, helping to reduce the viral load in the bloodstream and improve immune function. It is particularly beneficial for patients who have developed resistance to other antiretroviral therapies, providing an alternative option in the management of HIV.